ToolGen unsuccessful in landmark CRISPR patent appeal
The Federal Court of Australia has delivered judgement in Australia’s landmark CRISPR patent dispute, finding that none of the claims in ToolGen Inc.’s patent application for platform CRISPR technologies...
The Federal Court of Australia has delivered judgement in Australia’s landmark CRISPR patent dispute, finding that none of the...
Read More